UnicoCell Biomed Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	40.84	9.57	19.9	53.64	130.85
Short-Term Investments	692.08	518.37	457.38	160.25	10.17
Trading Asset Securities	13.35	22.3	-	-	-
Cash & Short-Term Investments	746.27	550.24	477.28	213.89	141.02
Cash Growth	35.63%	15.29%	123.15%	51.67%	-39.24%
Accounts Receivable	3.19	2.81	2.08	1.38	0.4
Other Receivables	19.37	19.6	18.08	13.47	12.02
Receivables	22.55	22.41	20.16	14.84	12.42
Inventory	9.27	9.75	7.5	7.98	7.83
Prepaid Expenses	3.31	3.66	1.61	1.13	2.04
Other Current Assets	5.75	6.29	0.24	0.06	-
Total Current Assets	787.16	592.35	506.8	237.9	163.31
Property, Plant & Equipment	138.04	152.59	175.89	173.36	131.21
Long-Term Investments	17.26	29	-	-	-
Other Intangible Assets	0.26	0.34	0.33	0.36	0.4
Other Long-Term Assets	3.29	3.61	2.92	2.7	2.8
Total Assets	946.01	777.89	685.93	414.31	297.71
Accounts Payable	1.23	1.97	0.11	0.91	0.08
Current Portion of Leases	6.35	6.22	6.09	5.93	8.95
Current Unearned Revenue	1.1	6.62	0.02	1.52	-
Other Current Liabilities	12.06	12.32	10.68	8.18	12.34
Total Current Liabilities	20.73	27.13	16.9	16.54	21.37
Long-Term Leases	55.67	62.02	68.24	60.66	12.63
Other Long-Term Liabilities	4.18	4.13	4.35	3.26	0.71
Total Liabilities	80.58	93.28	89.49	80.46	34.71
Common Stock	636.37	584.11	556.85	423.61	377.75
Additional Paid-In Capital	961.01	705.87	551.89	338.43	222.29
Retained Earnings	-720.2	-605.37	-512.29	-428.19	-337.03
Comprehensive Income & Other	-11.74	-	-	-	-
Shareholders' Equity	865.44	684.61	596.44	333.85	263.01
Total Liabilities & Equity	946.01	777.89	685.93	414.31	297.71
Total Debt	62.02	68.24	74.33	66.59	21.58
Net Cash (Debt)	684.25	482.01	402.95	147.3	119.44
Net Cash Growth	41.96%	19.62%	173.56%	23.32%	-39.71%
Net Cash Per Share	11.24	8.40	7.49	3.55	3.17
Filing Date Shares Outstanding	63.64	58.41	55.69	42.36	37.78
Total Common Shares Outstanding	63.64	58.41	55.69	42.36	37.78
Working Capital	766.43	565.22	489.9	221.36	141.94
Book Value Per Share	13.60	11.72	10.71	7.88	6.96
Tangible Book Value	865.18	684.27	596.12	333.5	262.61
Tangible Book Value Per Share	13.60	11.71	10.71	7.87	6.95
Machinery	73.95	70	67.02	65.56	60.92
Construction In Progress	-	-	-	-	68.3
Leasehold Improvements	99.39	98.28	97.5	93.25	16.35

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.